Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mazen Mohamed Salem Mohamed Rizk"'
Autor:
Amal Elham Fares, Hala Gabr, Asmaa Mohammed ShamsEldeen, Haithem A. M. Farghali, Mazen Mohamed Salem Mohamed Rizk, Bassem Essam Mahmoud, Ahmed Bakr Ahmed Tammam, Ayman Magdy Ahmed Mahmoud, Alaa Abdulfattah Mahmoud Suliman, Mohamed Abdelhamid Ali Ayyad, Sahar Hassan Ahmed, Rokia Mohamad Hassan
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-10 (2021)
Abstract Background and objectives The X-linked bleeding disorder, hemophilia A, is caused by defective production of factor VIII (FVIII). Hemophilic patients require regular FVIII infusions. Recombinant factor replacement poses the safest line of th
Externí odkaz:
https://doaj.org/article/8b428cd960b0496a95137d4ecb51544a
Autor:
Rokia Hassan, Alaa Abdulfattah Mahmoud Suliman, Haithem A. Farghali, Sahar H. Ahmed, Amal Elham Fares, Mazen Mohamed Salem Mohamed Rizk, Asmaa Mohammed ShamsEldeen, Ahmed Bakr Ahmed Tammam, Mohamed Abdelhamid Ali Ayyad, Hala Gabr, Bassem Essam Mahmoud, Ayman Magdy Ahmed Mahmoud
Publikováno v:
Stem Cell Research & Therapy
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-10 (2021)
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-10 (2021)
Background and objectives The X-linked bleeding disorder, hemophilia A, is caused by defective production of factor VIII (FVIII). Hemophilic patients require regular FVIII infusions. Recombinant factor replacement poses the safest line of therapy. Ho